SA
GMAB logo
Genmab A/S(GMAB)
Closing price · checked 8:25 PM ETAbout this dataData status
$50.60▼-0.75 (-1.46%)
Extended:$50.02-0.58 (-1.15%)· 8:25 PM ET

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 35.9 · very high volatility

Overview →

Genmab A/S (GMAB)

Common Stock Issued

$23.00M

TTM · Period ending: · USD

GMAB logo

GMAB Common Stock Issued

Latest reported$23.00M
GMAB Common Stock Issued ($159.77M → $23.00M)
Powered by
High-resolution chart · PNG

What is common stock issued?

Cash received from issuing common stock.

GMAB common stock issued history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years. Change compares each value with the period before it.

Genmab A/S Common Stock Issued — Annual fiscal periods (USD)
Period endingCommon Stock Issued (USD)Change
23,018,139—
0—
0—
0—
0—
0−100.00%
3,873,000,000—
0−100.00%
203,440,894+24,740.16%
819,000−68.06%
2,564,000−99.74%
998,200,000—
0−100.00%
366,390,000—
0—
0−100.00%
1,647,000−95.18%
34,145,000−97.82%
1,569,345,000+67.79%
935,315,000+204.63%
307,037,000−43.39%
542,344,000+67,608.36%
801,000−99.50%
159,772,000—

Frequently asked questions: GMAB common stock issued

What is Genmab A/S (GMAB)'s current common stock issued?

Genmab A/S (GMAB)'s latest reported common stock issued (TTM) is $23.00M as of Sep 30, 2026. Cash received from issuing common stock.

How much historical common stock issued data is available for GMAB?

Stock Alarm Pro provides 24 dated annual fiscal periods observations for Genmab A/S (GMAB)'s common stock issued, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.

How can I compare GMAB's common stock issued to peers or set an alert?

You can open GMAB's common stock issued in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on GMAB delivered by push, email, or phone call.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.